R&D efficiency has been in decline for many years, but now with bodies, like the FDA, aiming to accelerate approval times and a critical need for new therapies to combat antibiotic resistant strains of bacteria will we see the tide turn?
We talk to Dr Nik Marchetti, product manager of Lhasa Limited, a not-for-profit organisation and educational charity, about products, developments and innovations driving the company forwards.
The potential benefits of genomics are well documented in healthcare, European Pharmaceutical Manufacturer reporter Reece Armstrong examines the latest developments in the field.
Thanks to ongoing research and development in pharmaceuticals, the sector is benefitting from ongoing innovation which is helping break new boundaries in healthcare. Lu Rahman explains.
2017 is going to be a big year for pharma, with immunotherapy set to throw the industry under the spotlight – and hopefully, for all the right reasons.
Biopharmaceutical company, AstraZeneca has unveiled its NiCola-B drug discovery robot, capable of performing industrial scale experiments in the search for new, life-saving medicines.
Researchers at the University of Southern California (USC) and NASA’s Jet Propulsion Laboratory have come up with idea of launching fungi into space to create new medicine
